Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1514894
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1514894
IPV Vaccines Market, By Vaccine Type, By Age Group, By Distribution, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
PUBLISHED:
PAGES: 379 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
IPV Vaccines Market size was valued at USD 189.45 million in 2023, expanding at a CAGR of 8.3% from 2024 to 2032.
The IPV Vaccines Market, defined as the sector dedicated to inactivated poliovirus vaccines used for polio prevention, is experiencing growth driven by global immunization initiatives and increasing awareness of polio eradication. The robust government vaccination programs, support from organizations like WHO and UNICEF, and rising incidences of polio in certain regions are propelling the market demand. However, market growth is restrained by the high costs of vaccine development and distribution challenges in remote areas. Nonetheless, opportunities exist in the development of combination vaccines, advancements in vaccine storage and delivery technologies, and increasing investments in healthcare infrastructure in emerging economies.
IPV Vaccines Market- Market Dynamics
Increased Government Funding for Immunization Programs Fuels Adoption of IPV Vaccines
Increased government funding for immunization programs is significantly boosting the adoption of IPV vaccines, as evidenced by initiatives. For instance, in 2020, the World Health Organization (WHO) reported a 90% reduction in polio cases worldwide due to enhanced vaccination efforts. Additionally, the U.S. government allocated USD 237 million to polio eradication efforts in 2021, further emphasizing the commitment to widespread IPV vaccine distribution. These substantial investments are crucial in ensuring the availability and accessibility of IPV vaccines, ultimately driving higher immunization rates and bringing the goal of global polio eradication closer to reality.
IPV Vaccines Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.3% over the forecast period (2024-2032)
Based on Vaccine Type segmentation, IPV vaccines were predicted to show maximum market share in the year 2023
Based on Age Group segmentation, Pediatrics was the leading type in 2023
Based on distribution segmentation, Public Vaccination Programs were the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
IPV Vaccines Market- Segmentation Analysis:
The Global IPV vaccine market is segmented based on Vaccine Type, Age Group, Distribution, End-User, and Region.
The market is divided into two categories based on Vaccine Type: Inactivated Poliovirus Vaccine, and Oral Poliovirus Vaccine. The Inactivated Poliovirus Vaccine segment led the market, driven by its enhanced safety profile compared to the Oral Poliovirus Vaccine, alongside strong government support and international efforts aimed at polio eradication through IPV immunization programs.
The market is divided into two categories based on Age Group: Pediatrics, and Adults. The pediatrics segment holds the highest share, driven by global immunization programs targeting children to prevent polio from an early age, as mandated by healthcare guidelines and supported by extensive government and international initiatives.
IPV Vaccines Market- Geographical Insights
In North America, strong government support and robust healthcare systems ensure high adoption rates of IPV vaccines. Europe also demonstrates a significant market presence, driven by comprehensive immunization programs and initiatives like the European Vaccine Action Plan. Asia-Pacific, particularly India and China, represents a rapidly expanding segment due to large populations and aggressive polio eradication campaigns supported by both governments and international organizations like WHO and UNICEF. Africa, facing the highest polio prevalence, sees substantial efforts in IPV vaccine distribution funded by global health organizations, although challenges remain due to infrastructural limitations. Latin America shows steady market growth fueled by regional immunization drives and improving healthcare access.
IPV Vaccines Market- Competitive Landscape:
The IPV vaccine market is characterized by strong competition among leading pharmaceutical companies, each striving to enhance their market share through innovation, strategic alliances, and extensive distribution networks. Major players such as Sanofi Pasteur, GlaxoSmithKline, and Pfizer dominate the market, leveraging their extensive R&D capabilities and global reach to introduce effective and safe IPV vaccines. These companies frequently engage in partnerships with government bodies and global health organizations like WHO and UNICEF to support large-scale immunization programs. Emerging players and regional manufacturers are also entering the market, driven by increasing demand and supportive governmental policies. Additionally, advancements in vaccine technology, such as improved storage solutions and combination vaccines, are intensifying competition as companies seek to differentiate their offerings and expand their presence in both developed and developing regions.
Recent Developments:
In December 2023, Panacea Biotec launched EasyFourPol, a fully liquid pentavalent vaccine in India, safeguarding children against diphtheria, tetanus, pertussis, polio, and Haemophilus influenza type B infections.
In April 2024, The Business Standard announced India's capability to supply its entire IPV within 3-4 months, emphasizing the necessity of additional doses to sustain the nation's polio-free status. Sanofi and Serum Institute of India (SII) are identified as the primary IPV vaccine suppliers, with Sanofi contributing approximately 80% of the requirement.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IPV VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Sanofi Pasteur
GlaxoSmithKline plc
Pfizer Inc.
Merck & Co., Inc.
Johnson & Johnson
Serum Institute of India Pvt. Ltd.
Bharat Biotech
Panacea Biotec Ltd.
Bio Farma
Sinovac Biotech Ltd.
Astellas Pharma Inc.
Sinopharm Group Co., Ltd.
Valneva SE
Innovax
LG Chem
PT Bio Farma (Persero)
Others
GLOBAL IPV VACCINES MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019 - 2032
- Inactivated Poliovirus Vaccine (IPV)
- Oral Poliovirus Vaccine (OPV)
GLOBAL IPV VACCINES MARKET, BY AGE GROUP- MARKET ANALYSIS, 2019 - 2032
- Pediatrics
- Adults
GLOBAL IPV VACCINES MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032
- Public Vaccination Programs
- Private Vaccination Clinics
- Pharmacies
- Online Pharmacies
GLOBAL IPV VACCINES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Clinics
- Public Health Agencies
- Others
GLOBAL IPV VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV3035
Table of Contents
1. IPV Vaccines Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. IPV Vaccines Market Snippet by Vaccine Type
- 2.1.2. IPV Vaccines Market Snippet by Age Group
- 2.1.3. IPV Vaccines Market Snippet by Distribution
- 2.1.4. IPV Vaccines Market Snippet by End-User
- 2.1.5. IPV Vaccines Market Snippet by Country
- 2.1.6. IPV Vaccines Market Snippet by Region
- 2.2. Competitive Insights
3. IPV Vaccines Key Market Trends
- 3.1. IPV Vaccines Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. IPV Vaccines Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. IPV Vaccines Market Opportunities
- 3.4. IPV Vaccines Market Future Trends
4. IPV Vaccines Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. IPV Vaccines Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. IPV Vaccines Market Landscape
- 6.1. IPV Vaccines Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. IPV Vaccines Market - By Vaccine Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Vaccine Type, 2023 & 2032 (%)
- 7.1.2. Inactivated Poliovirus Vaccine (IPV)
- 7.1.3. Oral Poliovirus Vaccine (OPV)
8. IPV Vaccines Market - By Age Group
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Age Group, 2023 & 2032 (%)
- 8.1.2. Pediatrics
- 8.1.3. Adults
9. IPV Vaccines Market - By Distribution
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
- 9.1.2. Public Vaccination Programs
- 9.1.3. Private Vaccination Clinics
- 9.1.4. Pharmacies
- 9.1.5. Online Pharmacies
10. IPV Vaccines Market - By End-User
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 10.1.2. Hospitals
- 10.1.3. Clinics
- 10.1.4. Public Health Agencies
- 10.1.5. Others
11. IPV Vaccines Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. IPV Vaccines Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. IPV Vaccines Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.9.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.3.9.4. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.9.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.10.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.3.10.4. United Kingdom Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.11. France
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.11.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.3.11.4. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.11.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
- 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.12.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.3.12.3. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.12.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
- 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.13.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.3.13.3. Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.13.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.14.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
- 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.15.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.3.15.3. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.15.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.16.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.3.16.4. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. IPV Vaccines Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.8. India
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.8.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.4.8.4. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.8.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.9. China
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.9.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.4.9.4. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.9.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.13.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.4.13.4. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.13.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.14.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.4.14.4. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.14.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5. Latin America
- 11.5.1. Overview
- 11.5.2. IPV Vaccines Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. IPV Vaccines Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- IPV Vaccines Industry
- 12.1. Competitive Dashboard
- 12.2. Company Profiles
- 12.2.1. Sanofi Pasteur
- 12.2.2. GlaxoSmithKline plc
- 12.2.3. Pfizer Inc.
- 12.2.4. Merck & Co., Inc.
- 12.2.5. Johnson & Johnson
- 12.2.6. Serum Institute of India Pvt. Ltd.
- 12.2.7. Bharat Biotech
- 12.2.8. Panacea Biotec Ltd.
- 12.2.9. Bio Farma
- 12.2.10. Sinovac Biotech Ltd.
- 12.2.11. Astellas Pharma Inc.
- 12.2.12. Sinopharm Group Co., Ltd.
- 12.2.13. Valneva SE
- 12.2.14. Innovax
- 12.2.15. LG Chem
- 12.2.16. PT Bio Farma (Persero)
- 12.2.17. Others
13. 360 Degree Analyst View
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
Product Code: ANV3035
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE IPV Vaccines Market: Vaccine Type Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Vaccine Type
- TABLE Global IPV Vaccines Market, by Vaccine Type 2019-2032 (USD Million)
- TABLE IPV Vaccines Market: Age Group Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Age Group
- TABLE Global IPV Vaccines Market, by Age Group 2019-2032 (USD Million)
- TABLE IPV Vaccines Market: Distribution Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Distribution
- TABLE Global IPV Vaccines Market, by Distribution 2019-2032 (USD Million)
- TABLE IPV Vaccines Market: End-User Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by End-User
- TABLE Global IPV Vaccines Market, by End-User 2019-2032 (USD Million)
- TABLE IPV Vaccines Market: Regional snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global IPV Vaccines Market, by Region 2019-2032 (USD Million)
- TABLE North America IPV Vaccines Market, by Country, 2019-2032 (USD Million)
- TABLE North America IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
- TABLE North America IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
- TABLE North America IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
- TABLE North America IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
- TABLE Europe IPV Vaccines Market, by Country, 2019-2032 (USD Million)
- TABLE Europe IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
- TABLE Europe IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
- TABLE Europe IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
- TABLE Europe IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
- TABLE Asia Pacific IPV Vaccines Market, by Country, 2019-2032 (USD Million)
- TABLE Asia Pacific IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
- TABLE Asia Pacific IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
- TABLE Asia Pacific IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
- TABLE Asia Pacific IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
- TABLE Latin America IPV Vaccines Market, by Country, 2019-2032 (USD Million)
- TABLE Latin America IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
- TABLE Latin America IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
- TABLE Latin America IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
- TABLE Latin America IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
- TABLE Middle East and Africa IPV Vaccines Market, by Country, 2019-2032 (USD Million)
- TABLE Middle East and Africa IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
- TABLE Middle East and Africa IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
- TABLE Middle East and Africa IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
- TABLE Middle East and Africa IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
List of Figures
- FIGURE IPV Vaccines Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2023
- FIGURE Vaccine Type segment market share analysis, 2023 & 2032
- FIGURE Vaccine Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Age Group segment market share analysis, 2023 & 2032
- FIGURE Age Group segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Distribution segment market share analysis, 2023 & 2032
- FIGURE Distribution segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE End-User segment market share analysis, 2023 & 2032
- FIGURE End-User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Regional segment market share analysis, 2023 & 2032
- FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE North America IPV Vaccines Market share and leading players, 2023
- FIGURE Europe IPV Vaccines Market share and leading players, 2023
- FIGURE Asia Pacific IPV Vaccines Market share and leading players, 2023
- FIGURE Latin America IPV Vaccines Market share and leading players, 2023
- FIGURE Middle East and Africa IPV Vaccines Market share and leading players, 2023
- FIGURE North America market share analysis by country, 2023
- FIGURE U.S. IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Canada IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Europe IPV Vaccines Market share analysis by country, 2023
- FIGURE Germany IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Spain IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Italy IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE France IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE UK IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Russia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Netherlands IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Sweden IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Poland IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of the Europe IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Asia Pacific IPV Vaccines Market share analysis by country, 2023
- FIGURE India IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE China IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Japan IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE South Korea IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Australia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Thailand IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Indonesia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Philippines IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of APAC IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Latin America IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Latin America IPV Vaccines Market share analysis by country, 2023
- FIGURE Brazil IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Mexico IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Argentina IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Colombia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of LATAM IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Middle East and Africa IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Middle East and Africa IPV Vaccines Market share analysis by country, 2023
- FIGURE Saudi Arabia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE United Arab Emirates IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Israel IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Turkey IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Algeria IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Egypt IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of MEA IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.